Jamie Dimon’s latest interview had the kind of calm, polished menace Wall Street loves: the economy is sturdy, AI is real, bonds are not his favorite date, and government deficits are the sort of thing that tend to arrive uninvited and stay…
Wall Street is getting three reminders at once: geopolitics can still move oil and yields, defense demand remains durable, and medtech innovation is still finding ways to surprise investors. The result is a market story that feels less like a single headline…
U.S. stocks finished Wednesday with a mixed but relatively calm tone: the S&P 500 (^GSPC) rose 0.1% to 7,498.96, the Dow Jones Industrial Average (^DJI) slipped less than 0.1% to 52,218.58, and the Nasdaq Composite (^IXIC) fell 0.6% to 25,690.90. The move…
Repligen’s (REGN) $1.5 billion purchase of BioLife Solutions (BLFS) lands in the middle of a biotech M&A market that is getting bigger, faster, and a bit more strategic than the old “buy the science and hope for the best” model. The deal…
U.S. stocks rebounded on Tuesday, July 21, 2026, after Monday’s risk-off tone, with futures and sentiment improving as investors leaned into earnings strength and a modest easing in some geopolitical pressure. The best read for today is a “rotation-within-risk” tape: cyclicals and…
Sable Offshore Corp. (NYSE: SOC) and Similarweb Ltd. (NYSE: SMWB) add two very different—but highly instructive—chapters to the evolving energy and data narrative already being written by Vivakor Inc. (NASDAQ: VIVK), Exxon Mobil Corporation (NYSE: XOM) and Shell plc (NYSE: SHEL).
Offshore…
Hollywood just added a new kind of tentpole: the AI post‑production startup. Investors would be wise to pay attention, because behind the celebrity headlines around Ben Affleck’s InterPositive sale to Netflix sits an emerging stack that runs straight through NVIDIA (NVDA) and…
Sable Offshore Corp. (NYSE: SOC) is one of the market’s most combustible stories: a small-cap oil name with real production upside, serious legal overhangs, and enough headline voltage to keep traders awake and counsel employed. The investment case is not subtle, but…
Doximity Inc. (NYSE:DOCS) is quietly building one of Wall Street’s more compelling healthcare-tech narratives: a profitable, AI‑infused digital platform for U.S. clinicians that is leaning into clinical AI, telehealth, and value‑based care just as the medical establishment starts asking for them in…
Eli Lilly and Company’s (NYSE: LLY) recent equity investment in ŌURA Health and the Oura Ring ecosystem, paired with Modular Medical’s (NASDAQ: MODD) launch of its Pivot tubeless insulin patch pump, is giving Wall Street a preview of what next‑generation metabolic care…